Filing Details
JOHNSON & JOHNSON (NYSE:JNJ) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 21, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNYSE:JNJ
JOHNSON & JOHNSON (JNJ) Files Quarterly Report for Q0
JOHNSON & JOHNSON (NYSE:JNJ) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 21, 2026.
At publication ·
What changed
JOHNSON & JOHNSON (NYSE:JNJ) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Johnson & Johnson filed its Q0 2026 quarterly report (Form 10-Q) with the SEC on October 21, 2026.
- The company's stock trades at $257.78 with a market capitalization of $505.8 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
JOHNSON & JOHNSON's stock currently trades at $257.78 with a market capitalization of $505.8B.
The 10-Q provides JOHNSON & JOHNSON's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for JOHNSON & JOHNSON are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View JNJ Stock Page
Frequently Asked Questions
Where can I read JNJ's SEC filings?
Browse all filings on our JNJ SEC filings page.
What types of SEC filings does JOHNSON & JOHNSON file?
Public companies like JOHNSON & JOHNSON file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
